Giovanni Squadrito Selected Research

Blood Transfusion (Blood Transfusions)

1/2014	The clinical significance of occult HBV infection.
1/2007	Occult hepatitis B virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanni Squadrito Research Topics

Disease

14	Infections 01/2019 - 06/2002
13	Liver Diseases (Liver Disease) 04/2023 - 04/2005
9	Fibrosis (Cirrhosis) 01/2022 - 02/2003
6	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 03/2006
5	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 07/2022 - 03/2020
4	Wounds and Injuries (Trauma) 10/2021 - 04/2003
4	Chronic Hepatitis C 01/2021 - 06/2002
4	Chronic Hepatitis (Chronic Active Hepatitis) 01/2021 - 01/2004
4	Viremia 08/2012 - 06/2002
4	Hypotension (Low Blood Pressure) 05/2006 - 01/2002
4	Shock 05/2006 - 01/2002
3	Obesity 08/2023 - 03/2017
3	Inflammation (Inflammations) 06/2023 - 01/2020
3	Liver Cirrhosis (Hepatic Cirrhosis) 04/2023 - 09/2015
3	COVID-19 03/2023 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 11/2021
3	Colitis 01/2022 - 01/2016
3	Burns 04/2006 - 04/2003
2	Osteoporosis 07/2023 - 05/2022
2	Hemorrhage 05/2023 - 01/2002
2	Insulin Resistance 07/2022 - 03/2005
2	Non-alcoholic Fatty Liver Disease 07/2022 - 01/2022
2	Fatty Liver 07/2022 - 08/2010
2	Chronic Renal Insufficiency 05/2022 - 01/2021
2	Neoplasms (Cancer) 12/2021 - 01/2004
2	Hepatitis 10/2016 - 03/2002
2	Atrial Fibrillation 03/2016 - 09/2015
2	Chronic Hepatitis B 01/2011 - 01/2009
2	Persistent Infection 02/2003 - 03/2002
2	Hypovolemia 01/2003 - 01/2002
2	Hemorrhagic Shock 01/2003 - 01/2002
1	Chronic Disease (Chronic Diseases) 06/2023
1	Hemophilia B (Haemophilia B) 05/2023
1	Joint Diseases (Joint Disease) 05/2023
1	Hemophilia A (Haemophilia) 05/2023
1	Malnutrition (Nutritional Deficiencies) 05/2023
1	Hypertriglyceridemia 04/2023
1	Type 2 Diabetes Mellitus (MODY) 07/2022
1	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 07/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	End Stage Liver Disease 01/2022

Drug/Important Bio-Agent (IBA)

10	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2004
10	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017 - 06/2002
8	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2018
8	Surface Antigens (Surface Antigen)IBA 01/2022 - 03/2006
6	Messenger RNA (mRNA)IBA 05/2006 - 01/2002
5	Biomarkers (Surrogate Marker)IBA 08/2023 - 11/2021
5	PCSK9 InhibitorsIBA 07/2022 - 03/2020
5	EnzymesIBA 03/2017 - 04/2003
5	NF-kappa B (NF-kB)IBA 05/2006 - 01/2002
4	LipidsIBA 07/2022 - 03/2020
4	RNA (Ribonucleic Acid)IBA 01/2020 - 06/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2006 - 01/2002
4	NF-KappaB Inhibitor alphaIBA 05/2006 - 01/2002
4	Proteins (Proteins, Gene)FDA Link 07/2005 - 01/2002
3	Insulin (Novolin)FDA Link 07/2022 - 03/2005
3	PolydeoxyribonucleotidesIBA 01/2022 - 01/2016
3	AntigensIBA 01/2022 - 03/2002
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 03/2005
3	AutoantibodiesIBA 10/2016 - 02/2003
3	salicylhydroxamic acid (SHAM)IBA 05/2006 - 01/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2006 - 04/2003
2	GlucocorticoidsIBA 07/2023 - 10/2016
2	SodiumIBA 01/2022 - 10/2016
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2022 - 01/2016
2	Fibrinogen (Factor I)FDA Link 01/2020 - 03/2005
2	IodineIBA 01/2020 - 09/2015
2	Serum AlbuminIBA 01/2018 - 03/2016
2	flavocoxidIBA 01/2018 - 10/2016
2	dinitrobenzenesulfonic acidIBA 10/2016 - 01/2016
2	2,4-dinitrofluorobenzene sulfonic acidIBA 10/2016 - 01/2016
2	Ethanol (Ethyl Alcohol)IBA 10/2016 - 01/2016
2	Ribavirin (Virazole)FDA LinkGeneric 09/2014 - 01/2006
2	Hepatitis B e AntigensIBA 08/2012 - 03/2002
2	Immunoglobulin M (IgM)IBA 12/2011 - 06/2005
2	Lamivudine (Epivir)FDA Link 01/2011 - 01/2009
2	Transaminases (Aminotransferases)IBA 08/2010 - 06/2005
2	ImmunosorbentsIBA 04/2006 - 04/2003
2	NitritesIBA 07/2005 - 04/2003
2	RaxofelastIBA 07/2005 - 04/2005
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2005 - 04/2003
2	AntioxidantsIBA 04/2005 - 06/2002
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 07/2023
1	GenisteinIBA 07/2023
1	Infliximab (Remicade)FDA Link 06/2023
1	SteroidsIBA 06/2023
1	vedolizumabIBA 06/2023
1	Vitamin D FDA LinkGeneric 05/2023
1	Blood Coagulation Factors (Coagulation Factor)IBA 05/2023
1	CreatinineIBA 04/2023
1	Triglycerides (Triacylglycerol)IBA 04/2023
1	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2023
1	Vitamin K FDA Link 05/2022
1	A-factor (Streptomyces)IBA 01/2022
1	GoldIBA 01/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2022

Therapy/Procedure

10	Therapeutics 06/2023 - 01/2006
2	Blood Transfusion (Blood Transfusions) 01/2014 - 01/2007
1	Conservative Treatment 05/2023
1	Glycemic Control 04/2023